JP2023036007A5 - - Google Patents

Download PDF

Info

Publication number
JP2023036007A5
JP2023036007A5 JP2022136673A JP2022136673A JP2023036007A5 JP 2023036007 A5 JP2023036007 A5 JP 2023036007A5 JP 2022136673 A JP2022136673 A JP 2022136673A JP 2022136673 A JP2022136673 A JP 2022136673A JP 2023036007 A5 JP2023036007 A5 JP 2023036007A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
group
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022136673A
Other languages
English (en)
Japanese (ja)
Other versions
JP7483810B2 (ja
JP2023036007A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2023036007A publication Critical patent/JP2023036007A/ja
Publication of JP2023036007A5 publication Critical patent/JP2023036007A5/ja
Priority to JP2024074339A priority Critical patent/JP2024112817A/ja
Application granted granted Critical
Publication of JP7483810B2 publication Critical patent/JP7483810B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022136673A 2021-08-31 2022-08-30 6-アミノピラゾロピリミジン化合物及びその医薬用途 Active JP7483810B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024074339A JP2024112817A (ja) 2021-08-31 2024-05-01 6-アミノピラゾロピリミジン化合物及びその医薬用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2021141253 2021-08-31
JP2021141253 2021-08-31
JP2022068967 2022-04-19
JP2022068967 2022-04-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024074339A Division JP2024112817A (ja) 2021-08-31 2024-05-01 6-アミノピラゾロピリミジン化合物及びその医薬用途

Publications (3)

Publication Number Publication Date
JP2023036007A JP2023036007A (ja) 2023-03-13
JP2023036007A5 true JP2023036007A5 (https=) 2024-01-11
JP7483810B2 JP7483810B2 (ja) 2024-05-15

Family

ID=85411220

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022136673A Active JP7483810B2 (ja) 2021-08-31 2022-08-30 6-アミノピラゾロピリミジン化合物及びその医薬用途
JP2024074339A Withdrawn JP2024112817A (ja) 2021-08-31 2024-05-01 6-アミノピラゾロピリミジン化合物及びその医薬用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024074339A Withdrawn JP2024112817A (ja) 2021-08-31 2024-05-01 6-アミノピラゾロピリミジン化合物及びその医薬用途

Country Status (15)

Country Link
US (1) US20240287079A1 (https=)
EP (1) EP4397663A4 (https=)
JP (2) JP7483810B2 (https=)
KR (1) KR20240055035A (https=)
AR (1) AR126912A1 (https=)
AU (1) AU2022340126A1 (https=)
CA (1) CA3229401A1 (https=)
CL (1) CL2024000581A1 (https=)
CO (1) CO2024002515A2 (https=)
IL (1) IL310062A (https=)
MX (1) MX2024002609A (https=)
PE (1) PE20240882A1 (https=)
TW (1) TW202328134A (https=)
WO (1) WO2023032987A1 (https=)
ZA (1) ZA202400656B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR130318A1 (es) * 2022-08-29 2024-11-27 Japan Tobacco Inc Compuestos de pirazolopirimidina y su uso médico
WO2024177127A1 (ja) * 2023-02-24 2024-08-29 日本たばこ産業株式会社 置換ピラゾロピリミジン化合物及びその医薬用途
EP4671246A1 (en) * 2023-02-24 2025-12-31 Japan Tobacco Inc. COMPOSITE OF 6-ALCOXYPYRAZOLOPYRIMIDINE AND ITS PHARMACEUTICAL USE
EP4694980A1 (en) 2023-04-14 2026-02-18 Takeda Pharmaceutical Company Limited Pyrazolopyrimidine derivatives as inhibitors of nlrp3
AU2024280075A1 (en) 2023-06-02 2025-12-11 Merck Sharp & Dohme Llc 5,6-Unsaturated Bicyclic Heterocycles Useful as Inhibitors of Nod-Like Receptor Protein 3
US20250223290A1 (en) * 2023-12-14 2025-07-10 Merck Sharp & Dohme Llc Azaindazole derivatives useful as inhibitors of nod-like receptor protein 3
AR134646A1 (es) * 2023-12-14 2026-02-04 Merck Sharp & Dohme Llc Derivados de indazol útiles como inhibidores de la proteína 3 del receptor similar a nod
CN120230110A (zh) * 2023-12-31 2025-07-01 杭州百新生物医药科技有限公司 吡唑并嘧啶类化合物及其医药用途
WO2025153532A1 (en) 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX363696B (es) 2011-04-21 2019-03-28 Origenis Gmbh Pirazolo[4,3-d]pirimidinas utiles como inhibidores de cinasas.
WO2017205766A1 (en) * 2016-05-27 2017-11-30 Pharmacyclics Llc Inhibitors of interleukin-1 receptor-associated kinase
ES2930151T3 (es) 2019-01-14 2022-12-07 Innate Tumor Immunity Inc Moduladores heterocíclicos de NLRP3, para su uso en el tratamiento del cáncer
EP3911641A1 (en) 2019-01-14 2021-11-24 Innate Tumor Immunity, Inc. Nlrp3 modulators

Similar Documents

Publication Publication Date Title
JP2023036007A5 (https=)
JP2024032686A5 (https=)
JP2024050527A5 (https=)
RU2472509C2 (ru) Способ лечения артрита
JP2024120882A5 (https=)
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2014506907A5 (https=)
RU2005127356A (ru) Новая кристаллическая форма триазоло (4,5-d) пиримидина
JPWO2024177126A5 (https=)
JP2012521994A5 (https=)
JP2005505506A5 (https=)
JP2020507589A5 (https=)
RS53467B (sr) Upotreba amisulprida za tretiranje mučnine i povraćanja izazvanih hemoterapijom
IL296282B2 (en) Fluorophenyl beta-hydroxyethylamines and their uses in the treatment of hyperglycemia
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2005502621A5 (https=)
JP2018534288A5 (https=)
JP2020511536A5 (https=)
JP2019518779A5 (https=)
JP2010505865A5 (https=)
JP2020506878A5 (https=)
JP2020531463A5 (https=)
JP2018509426A5 (https=)
JP2025118775A5 (https=)